Jon Congleton
CEO, Mineralys Therapeutics, Inc.
Companies#
| Company | Role | World rank | Market cap | Since Jan 2024 |
|---|---|---|---|---|
| Mineralys Therapeutics, Inc.🇺🇸 | CEO | #6,163 | $2.1 B | +491.7% |
Jon Congleton's share trades#
Shares Jon Congleton reported buying, selling or receiving on SEC Form 4 as an insider: $106 K bought and $19.3 M sold on the open market in all.
| Traded | Company | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | 🇺🇸 Mineralys Therapeutics, Inc.MLYS | Sell10b5-1 plan | -75,000 | $25.46 | $1.9 M | 528,621 | Form 4 |
| filed | 🇺🇸 Mineralys Therapeutics, Inc.MLYS | Sell10b5-1 plan | -10,700 | $27.24 | $291 K | 603,621 | Form 4 |
| filed | 🇺🇸 Mineralys Therapeutics, Inc.MLYS | Sell10b5-1 plan | -58,000 | $25.94 | $1.5 M | 631,321 | Form 4 |
| filed | 🇺🇸 Mineralys Therapeutics, Inc.MLYS | Sell10b5-1 plan | -17,000 | $26.82 | $456 K | 614,321 | Form 4 |
| filed | 🇺🇸 Mineralys Therapeutics, Inc.MLYS | Sell10b5-1 plan | -15,730 | $26.83 | $422 K | 689,321 | Form 4 |
| filed | 🇺🇸 Mineralys Therapeutics, Inc.MLYS | Sell10b5-1 plan | -19,364 | $25.50 | $494 K | 760,687 | Form 4 |
| filed | 🇺🇸 Mineralys Therapeutics, Inc.MLYS | Sell10b5-1 plan | -55,183 | $26.54 | $1.5 M | 705,504 | Form 4 |
| filed | 🇺🇸 Mineralys Therapeutics, Inc.MLYS | Sell10b5-1 plan | -453 | $27.05 | $12 K | 705,051 | Form 4 |
| filed | 🇺🇸 Mineralys Therapeutics, Inc.MLYS | Grant or award | +140,900 | — | — | 780,051 | Form 4 |
| filed | 🇺🇸 Mineralys Therapeutics, Inc.MLYS | Sell10b5-1 plan | -9,119 | $32.21 | $294 K | 646,268 | Form 4 |
| filed | 🇺🇸 Mineralys Therapeutics, Inc.MLYS | Sell10b5-1 plan | -7,117 | $33.15 | $236 K | 639,151 | Form 4 |
| filed | 🇺🇸 Mineralys Therapeutics, Inc.MLYS | Option exercise | +24,082 | $0.540 | — | 655,387 | Form 4 |
| filed | 🇺🇸 Mineralys Therapeutics, Inc.MLYS | Sell | -12,806 | $41.64 | $533 K | 818,499 | Form 4 |
| filed | 🇺🇸 Mineralys Therapeutics, Inc.MLYS | Sell | -8,862 | $42.31 | $375 K | 809,637 | Form 4 |
| filed | 🇺🇸 Mineralys Therapeutics, Inc.MLYS | Sell | -4,000 | $43.50 | $174 K | 805,637 | Form 4 |
| filed | 🇺🇸 Mineralys Therapeutics, Inc.MLYS | Sell | -29,207 | $45.20 | $1.3 M | 776,430 | Form 4 |
| filed | 🇺🇸 Mineralys Therapeutics, Inc.MLYS | Sell | -112,275 | $45.83 | $5.1 M | 664,155 | Form 4 |
| filed | 🇺🇸 Mineralys Therapeutics, Inc.MLYS | Sell | -32,850 | $46.89 | $1.5 M | 631,305 | Form 4 |
| filed | 🇺🇸 Mineralys Therapeutics, Inc.MLYS | Sell10b5-1 plan | -13,548 | $42.63 | $578 K | 832,857 | Form 4 |
| filed | 🇺🇸 Mineralys Therapeutics, Inc.MLYS | Sell10b5-1 plan | -1,552 | $43.03 | $67 K | 831,305 | Form 4 |
| filed | 🇺🇸 Mineralys Therapeutics, Inc.MLYS | Sell10b5-1 plan | -15,884 | $14.51 | $230 K | 846,405 | Form 4 |
| filed | 🇺🇸 Mineralys Therapeutics, Inc.MLYS | Sell10b5-1 plan | -15,319 | $12.19 | $187 K | 862,289 | Form 4 |
| filed | 🇺🇸 Mineralys Therapeutics, Inc.MLYS | Sell10b5-1 plan | -18,333 | $9.060 | $166 K | 877,608 | Form 4 |
| filed | 🇺🇸 Mineralys Therapeutics, Inc.MLYS | Sell10b5-1 plan | -15,271 | $13.52 | $206 K | 895,941 | Form 4 |
| filed | 🇺🇸 Mineralys Therapeutics, Inc.MLYS | Sell10b5-1 plan | -15,746 | $13.34 | $210 K | 911,212 | Form 4 |